메뉴 건너뛰기




Volumn 23, Issue SUPPL. 1, 2005, Pages 12-19

Calcium loading, calcium accumulation, and associated cardiovascular risks in dialysis patients

Author keywords

Calcification; Calcium balance; Calcium load; Cardiovascular disease; Hyperphosphatemia; Phosphate binder

Indexed keywords

CALCIMIMETIC AGENT; CALCIUM; CALCIUM ACETATE; CALCIUM CARBONATE; CINACALCET; FETUIN; METAL; PHOSPHATE; PHOSPHATE BINDING AGENT; SEVELAMER; VITAMIN D; VITAMIN D DERIVATIVE; VITAMIN K GROUP; WARFARIN;

EID: 20844446151     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083713     Document Type: Review
Times cited : (16)

References (82)
  • 1
    • 0030951074 scopus 로고    scopus 로고
    • Are we mismanaging calcium and phosphate metabolism in renal failure?
    • Hsu CH: Are we mismanaging calcium and phosphate metabolism in renal failure? Am J Kidney Dis 1997;29:641-649.
    • (1997) Am J Kidney Dis , vol.29 , pp. 641-649
    • Hsu, C.H.1
  • 2
    • 0033941584 scopus 로고    scopus 로고
    • Calcific small vessel ischemic disease (calciphylaxis) in dialysis patients
    • Bleyer AJ, White WL, Choi MJ: Calcific small vessel ischemic disease (calciphylaxis) in dialysis patients. Int J Artif Organs 2000;23:351-355.
    • (2000) Int J Artif Organs , vol.23 , pp. 351-355
    • Bleyer, A.J.1    White, W.L.2    Choi, M.J.3
  • 4
    • 0027991769 scopus 로고
    • Evidence for abnormal calcium homeostasis in patients with adynamic bone disease
    • Kurz P, Monier-Faugere MC, Bognar B, et al: Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int 1994;46:855-861.
    • (1994) Kidney Int , vol.46 , pp. 855-861
    • Kurz, P.1    Monier-Faugere, M.C.2    Bognar, B.3
  • 5
    • 0032848336 scopus 로고    scopus 로고
    • Calcific uremic arteriolopathy in association with low turnover uremic bone disease
    • Mawad HW, Sawaya BP, Sarin R, et al: Calcific uremic arteriolopathy in association with low turnover uremic bone disease. Clin Nephrol 1999;52:160-166.
    • (1999) Clin Nephrol , vol.52 , pp. 160-166
    • Mawad, H.W.1    Sawaya, B.P.2    Sarin, R.3
  • 6
    • 0342588049 scopus 로고    scopus 로고
    • Arterial stiffening and vascular calcifications in end-stage renal disease
    • Guerin AP, London GM, Marchais SJ, et al: Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 2000;15:1014-1021.
    • (2000) Nephrol Dial Transplant , vol.15 , pp. 1014-1021
    • Guerin, A.P.1    London, G.M.2    Marchais, S.J.3
  • 7
    • 0036178297 scopus 로고    scopus 로고
    • Cardiovascular calcification in end-stage renal disease
    • Salusky IB, Goodman WG: Cardiovascular calcification in end-stage renal disease. Nephrol Dial Transplant 2002;17:336-339.
    • (2002) Nephrol Dial Transplant , vol.17 , pp. 336-339
    • Salusky, I.B.1    Goodman, W.G.2
  • 8
    • 0030008101 scopus 로고    scopus 로고
    • Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients
    • Braun J, Oldendorf M, Moshage W, et al: Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 1996;27:394-401.
    • (1996) Am J Kidney Dis , vol.27 , pp. 394-401
    • Braun, J.1    Oldendorf, M.2    Moshage, W.3
  • 9
    • 0036310682 scopus 로고    scopus 로고
    • Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
    • Chertow GM, Burke SK, Raggi P: Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002;62:245-252.
    • (2002) Kidney Int , vol.62 , pp. 245-252
    • Chertow, G.M.1    Burke, S.K.2    Raggi, P.3
  • 10
    • 0034682247 scopus 로고    scopus 로고
    • Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis
    • Goodman WG, Goldin J, Kuizon BD, et al: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000;342:1478-1483.
    • (2000) N Engl J Med , vol.342 , pp. 1478-1483
    • Goodman, W.G.1    Goldin, J.2    Kuizon, B.D.3
  • 11
    • 0037138580 scopus 로고    scopus 로고
    • Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?
    • Raggi P, Boulay A, Chasan-Taber S, et al: Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 2002;39:695-701.
    • (2002) J Am Coll Cardiol , vol.39 , pp. 695-701
    • Raggi, P.1    Boulay, A.2    Chasan-Taber, S.3
  • 12
    • 10744227063 scopus 로고    scopus 로고
    • The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients
    • Chertow GM, Raggi P, McCarthy JT, et al: The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients. Am J Nephrol 2003;23:307-314.
    • (2003) Am J Nephrol , vol.23 , pp. 307-314
    • Chertow, G.M.1    Raggi, P.2    McCarthy, J.T.3
  • 13
    • 0042885985 scopus 로고    scopus 로고
    • Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality
    • London GM, Guerin AP, Marchais SJ, et al: Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003;18:1731-1740.
    • (2003) Nephrol Dial Transplant , vol.18 , pp. 1731-1740
    • London, G.M.1    Guerin, A.P.2    Marchais, S.J.3
  • 14
    • 0037337818 scopus 로고    scopus 로고
    • Uremia induces the osteoblast differentiation factor Cbfal in human blood vessels
    • Moe SM, Duan D, Doehle BP, et al: Uremia induces the osteoblast differentiation factor Cbfal in human blood vessels. Kidney Int 2003;63:1003-1011.
    • (2003) Kidney Int , vol.63 , pp. 1003-1011
    • Moe, S.M.1    Duan, D.2    Doehle, B.P.3
  • 15
    • 0034730291 scopus 로고    scopus 로고
    • Phosphate regulation of vascular smooth muscle cell calcification
    • Jono S, McKee MD, Murry CE, et al: Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000;87:E10-E17.
    • (2000) Circ Res , vol.87
    • Jono, S.1    McKee, M.D.2    Murry, C.E.3
  • 16
    • 0034806050 scopus 로고    scopus 로고
    • Vascular calcification and inorganic phosphate
    • Giachelli CM, Jono S, Shioi A, et al: Vascular calcification and inorganic phosphate. Am J Kidney Dis 2001;38:S34-S37.
    • (2001) Am J Kidney Dis , vol.38
    • Giachelli, C.M.1    Jono, S.2    Shioi, A.3
  • 17
    • 0141919775 scopus 로고    scopus 로고
    • Mineral exploration: Search for the mechanism of vascular calcification and beyond: the 2003 Jeffrey M. Hoeg Award lecture
    • Demer LL, Tintut Y: Mineral exploration: Search for the mechanism of vascular calcification and beyond: The 2003 Jeffrey M. Hoeg Award lecture. Arterioscler Thromb Vasc Biol 2003;23:1739-1743.
    • (2003) Arterioscler Thromb Vasc Biol , vol.23 , pp. 1739-1743
    • Demer, L.L.1    Tintut, Y.2
  • 18
    • 0035725506 scopus 로고    scopus 로고
    • Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease
    • Blacher J, Guerin AP, Pannier B, et al: Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001;38:938-942.
    • (2001) Hypertension , vol.38 , pp. 938-942
    • Blacher, J.1    Guerin, A.P.2    Pannier, B.3
  • 19
    • 0041318888 scopus 로고    scopus 로고
    • Cardiovascular calcifications in uremic patients: Clinical impact on cardiovascular function
    • London GM: Cardiovascular calcifications in uremic patients: clinical impact on cardiovascular function. J Am Soc Nephrol 2003;14:S305-S309.
    • (2003) J Am Soc Nephrol , vol.14
    • London, G.M.1
  • 20
    • 0034084251 scopus 로고    scopus 로고
    • Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management
    • Block GA, Port FK: Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management. Am J Kidney Dis 2000;35:1226-1237.
    • (2000) Am J Kidney Dis , vol.35 , pp. 1226-1237
    • Block, G.A.1    Port, F.K.2
  • 21
    • 84979435871 scopus 로고
    • Atherogenesis: Is it accelerated in uremia?
    • Ritz E, Querfeld U: Atherogenesis: Is it accelerated in uremia? Semin Dial 1989;2:246-252.
    • (1989) Semin Dial , vol.2 , pp. 246-252
    • Ritz, E.1    Querfeld, U.2
  • 22
    • 0034922853 scopus 로고    scopus 로고
    • Pathophysiological mechanisms of vascular calcification in end-stage renal disease
    • Davies MR, Hruska KA: Pathophysiological mechanisms of vascular calcification in end-stage renal disease. Kidney Int 2001;60:472-479.
    • (2001) Kidney Int , vol.60 , pp. 472-479
    • Davies, M.R.1    Hruska, K.A.2
  • 23
    • 0031733696 scopus 로고    scopus 로고
    • Clinical epidemiology of cardiovascular disease in chronic renal disease
    • Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32:S112-S119.
    • (1998) Am J Kidney Dis , vol.32
    • Foley, R.N.1    Parfrey, P.S.2    Sarnak, M.J.3
  • 24
    • 0019457009 scopus 로고
    • Jejunal and ileal adaptation to alterations in dietary calcium: Changes in calcium and magnesium absorption and pathogenetic role of parathyroid hormone and 1,25-dihydroxyvitamin D
    • Norman DA, Fordtran JS, Brinkley LJ, et al: Jejunal and ileal adaptation to alterations in dietary calcium: Changes in calcium and magnesium absorption and pathogenetic role of parathyroid hormone and 1,25-dihydroxyvitamin D. J Clin Invest 1981;67:1599-1603.
    • (1981) J Clin Invest , vol.67 , pp. 1599-1603
    • Norman, D.A.1    Fordtran, J.S.2    Brinkley, L.J.3
  • 25
    • 0026660119 scopus 로고
    • Calcium balance during human growth: Evidence for threshold behavior
    • Matkovic V, Heaney RP: Calcium balance during human growth: Evidence for threshold behavior. Am J Clin Nutr 1992;55:992-996.
    • (1992) Am J Clin Nutr , vol.55 , pp. 992-996
    • Matkovic, V.1    Heaney, R.P.2
  • 26
    • 0021720449 scopus 로고
    • Calcium and phosphorus intakes, balances, and blood levels of adults consuming self-selected diets
    • Lakshmanan FL, Rao RB, Church JP: Calcium and phosphorus intakes, balances, and blood levels of adults consuming self-selected diets. Am J Clin Nutr 1984;40:1368-1379.
    • (1984) Am J Clin Nutr , vol.40 , pp. 1368-1379
    • Lakshmanan, F.L.1    Rao, R.B.2    Church, J.P.3
  • 27
    • 0033839073 scopus 로고    scopus 로고
    • Adynamic bone and chronic renal failure: An overview
    • Cannata Andia JB: Adynamic bone and chronic renal failure: An overview. Am J Med Sci 2000;320:81-84.
    • (2000) Am J Med Sci , vol.320 , pp. 81-84
    • Cannata Andia, J.B.1
  • 28
    • 0029773621 scopus 로고    scopus 로고
    • The aplastic form of renal osteodystrophy
    • Sherrard DJ, Hercz G, Pei Y, et al: The aplastic form of renal osteodystrophy. Nephrol Dial Transplant 1996;11(suppl 3):29-31.
    • (1996) Nephrol Dial Transplant , vol.11 , Issue.SUPPL. 3 , pp. 29-31
    • Sherrard, D.J.1    Hercz, G.2    Pei, Y.3
  • 29
    • 0015120990 scopus 로고
    • Calcium absorption in renal failure: Its relationship to blood urea nitrogen, dietary calcium intake, time on dialysis, and other variables
    • Recker RR, Saville PD: Calcium absorption in renal failure: Its relationship to blood urea nitrogen, dietary calcium intake, time on dialysis, and other variables. J Lab Clin Med 1971;78:380-388.
    • (1971) J Lab Clin Med , vol.78 , pp. 380-388
    • Recker, R.R.1    Saville, P.D.2
  • 30
    • 0014379119 scopus 로고
    • The effect of aluminum hydroxide in serum calcium, serum phosphorus and calcium turnover in uraemic patients
    • Friis T, Weeks E: The effect of aluminum hydroxide in serum calcium, serum phosphorus and calcium turnover in uraemic patients. Calcif Tissue Res 1968(suppl 58).
    • (1968) Calcif Tissue Res , Issue.SUPPL. 58
    • Friis, T.1    Weeks, E.2
  • 31
    • 0014508481 scopus 로고
    • The interrelationship between sodium, calcium, and magnesium excretion in advanced renal failure
    • Popovtzer MM, Massry SG, Coburn JW, et al: The interrelationship between sodium, calcium, and magnesium excretion in advanced renal failure. J Lab Clin Med 1969;73:763-771.
    • (1969) J Lab Clin Med , vol.73 , pp. 763-771
    • Popovtzer, M.M.1    Massry, S.G.2    Coburn, J.W.3
  • 32
    • 0015614875 scopus 로고
    • Net intestinal absorption of calcium in patients with chronic renal failure
    • Clarkson EM, Eastwood JB, Koutsaimanis KG, et al: Net intestinal absorption of calcium in patients with chronic renal failure. Kidney Int 1973;3:258-263.
    • (1973) Kidney Int , vol.3 , pp. 258-263
    • Clarkson, E.M.1    Eastwood, J.B.2    Koutsaimanis, K.G.3
  • 33
    • 0006787386 scopus 로고
    • Metabolic studies of renal osteodystrophy. I. Calcium, phosphorus and nitrogen metabolism in rickets, osteomalacia and hyperparathyroidism complicating chronic uremia and in the osteomalacia of the adult Fanconi syndrome
    • (Baltimore)
    • Stanbury SW, Lumb GA: Metabolic studies of renal osteodystrophy. I. Calcium, phosphorus and nitrogen metabolism in rickets, osteomalacia and hyperparathyroidism complicating chronic uremia and in the osteomalacia of the adult Fanconi syndrome. Medicine (Baltimore) 1962;41:1-34.
    • (1962) Medicine , vol.41 , pp. 1-34
    • Stanbury, S.W.1    Lumb, G.A.2
  • 34
    • 0015616565 scopus 로고
    • Study of intestinal absorption of calcium in patients with renal failure
    • Coburn JW, Koppel MH, Brickman AS, et al: Study of intestinal absorption of calcium in patients with renal failure. Kidney Int 1973;3:264-272.
    • (1973) Kidney Int , vol.3 , pp. 264-272
    • Coburn, J.W.1    Koppel, M.H.2    Brickman, A.S.3
  • 35
    • 0026040622 scopus 로고
    • Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate
    • Hou SH, Zhao J, Ellman CF, et al: Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate. Am J Kidney Dis 1991;18:217-224.
    • (1991) Am J Kidney Dis , vol.18 , pp. 217-224
    • Hou, S.H.1    Zhao, J.2    Ellman, C.F.3
  • 36
    • 84942950200 scopus 로고
    • The Burnett or milk-alkali syndrome
    • The Burnett or milk-alkali syndrome: J Am Med Assoc 1955;157:1220.
    • (1955) J Am Med Assoc , vol.157 , pp. 1220
  • 37
    • 0030020763 scopus 로고    scopus 로고
    • Rolaids-yogurt syndrome: A 1990s version of milk-alkali syndrome
    • Muldowney WP, Mazbar SA: Rolaids-yogurt syndrome: A 1990s version of milk-alkali syndrome. Am J Kidney Dis 1996;27:270-272.
    • (1996) Am J Kidney Dis , vol.27 , pp. 270-272
    • Muldowney, W.P.1    Mazbar, S.A.2
  • 38
    • 0028806821 scopus 로고
    • Calcium balance and intact PTH variations during haemodiafiltration
    • Argiles A, Mion CM: Calcium balance and intact PTH variations during haemodiafiltration. Nephrol Dial Transplant 1995;10:2083-2089.
    • (1995) Nephrol Dial Transplant , vol.10 , pp. 2083-2089
    • Argiles, A.1    Mion, C.M.2
  • 39
    • 0029870659 scopus 로고    scopus 로고
    • Intradialytic calcium balances with different calcium dialysate levels. Effects on cardiovascular stability and parathyroid function
    • Fabrizi F, Bacchini G, Di Filippo S, et al: Intradialytic calcium balances with different calcium dialysate levels. Effects on cardiovascular stability and parathyroid function. Nephron 1996;72:530-535.
    • (1996) Nephron , vol.72 , pp. 530-535
    • Fabrizi, F.1    Bacchini, G.2    Di Filippo, S.3
  • 40
    • 0032893490 scopus 로고    scopus 로고
    • Calcium balance during pulse alfacalcidol therapy for secondary hyperparathyroidism in CAPD patients treated with 1.0 and 1.25 mmol/l dialysate calcium
    • Chagnac A, Ori Y, Weinstein T, et al: Calcium balance during pulse alfacalcidol therapy for secondary hyperparathyroidism in CAPD patients treated with 1.0 and 1.25 mmol/l dialysate calcium. Am J Kidney Dis 1999;33:82-86.
    • (1999) Am J Kidney Dis , vol.33 , pp. 82-86
    • Chagnac, A.1    Ori, Y.2    Weinstein, T.3
  • 41
    • 0025855058 scopus 로고
    • Calcium acetate control of serum phosphorus in hemodialysis patients
    • Emmett M, Sirmon MD, Kirkpatrick WG, et al: Calcium acetate control of serum phosphorus in hemodialysis patients. Am J Kidney Dis 1991;17:544-550.
    • (1991) Am J Kidney Dis , vol.17 , pp. 544-550
    • Emmett, M.1    Sirmon, M.D.2    Kirkpatrick, W.G.3
  • 42
    • 0002028239 scopus 로고
    • Use of alkaline calcium salts as phosphate binder in uremic patients
    • Fournier A, Moriniere P, Ben Hamida F, et al: Use of alkaline calcium salts as phosphate binder in uremic patients. Kidney Int Suppl 1992;38:S50-S61.
    • (1992) Kidney Int Suppl , vol.38
    • Fournier, A.1    Moriniere, P.2    Ben Hamida, F.3
  • 43
    • 3042528668 scopus 로고    scopus 로고
    • Arterial calcifications and bone histomorphometry in end-stage renal disease
    • London GM, Marty C, Marchais SJ, et al: Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 2004;15:1943-1951.
    • (2004) J Am Soc Nephrol , vol.15 , pp. 1943-1951
    • London, G.M.1    Marty, C.2    Marchais, S.J.3
  • 44
    • 3543139492 scopus 로고    scopus 로고
    • Mineral metabolism, mortality, and morbidity in maintenance hemodialysis
    • Block GA, Klassen PS, Lazarus JM, et al: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004;15:2208-2218.
    • (2004) J Am Soc Nephrol , vol.15 , pp. 2208-2218
    • Block, G.A.1    Klassen, P.S.2    Lazarus, J.M.3
  • 45
    • 5644225678 scopus 로고    scopus 로고
    • Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS)
    • Young EW, Akiba T, Albert JM, et al: Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004;44:34-38.
    • (2004) Am J Kidney Dis , vol.44 , pp. 34-38
    • Young, E.W.1    Akiba, T.2    Albert, J.M.3
  • 46
    • 9644298257 scopus 로고    scopus 로고
    • Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro
    • Yang H, Curinga G, Giachelli CM: Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro. Kidney Int 2004;66:2293-2299.
    • (2004) Kidney Int , vol.66 , pp. 2293-2299
    • Yang, H.1    Curinga, G.2    Giachelli, C.M.3
  • 47
    • 0024229219 scopus 로고
    • Myocardial calcification and cardiac dysfunction in chronic renal failure
    • Rostand SG, Sanders C, Kirk KA, et al: Myocardial calcification and cardiac dysfunction in chronic renal failure. Am J Med 1988;85:651-657.
    • (1988) Am J Med , vol.85 , pp. 651-657
    • Rostand, S.G.1    Sanders, C.2    Kirk, K.A.3
  • 48
    • 0033993755 scopus 로고    scopus 로고
    • Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography
    • Raggi P, Callister TQ, Cooil B, et al: Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation 2000;101:850-855.
    • (2000) Circulation , vol.101 , pp. 850-855
    • Raggi, P.1    Callister, T.Q.2    Cooil, B.3
  • 49
    • 33750600232 scopus 로고    scopus 로고
    • Osteoprotegerin and vascular calcification in hemodialysis patients
    • Nitta K, Akiba T, Horita S, Uchida, K, Nihei H: Osteoprotegerin and vascular calcification in hemodialysis patients. J Am Soc Neph 2003;14:695A.
    • (2003) J Am Soc Neph , vol.14
    • Nitta, K.1    Akiba, T.2    Horita, S.3    Uchida, K.4    Nihei, H.5
  • 50
    • 0042126983 scopus 로고    scopus 로고
    • The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis
    • Nitta K, Akiba T, Uchida K, et al: The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis. Am J Kidney Dis 2003;42:303-309.
    • (2003) Am J Kidney Dis , vol.42 , pp. 303-309
    • Nitta, K.1    Akiba, T.2    Uchida, K.3
  • 51
    • 1542347890 scopus 로고    scopus 로고
    • Vascular calcification in chronic kidney disease
    • Goodman WG, London G, Amann K, et al: Vascular calcification in chronic kidney disease. Am J Kidney Dis 2004;43:572-579.
    • (2004) Am J Kidney Dis , vol.43 , pp. 572-579
    • Goodman, W.G.1    London, G.2    Amann, K.3
  • 52
    • 0034995079 scopus 로고    scopus 로고
    • Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells
    • Ahmed S, O'Neill KD, Hood AF, et al: Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells. Am J Kidney Dis 2001;37:1267-1276.
    • (2001) Am J Kidney Dis , vol.37 , pp. 1267-1276
    • Ahmed, S.1    O'Neill, K.D.2    Hood, A.F.3
  • 53
    • 0036406957 scopus 로고    scopus 로고
    • Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells
    • Chen NX, O'Neill KD, Duan D, et al: Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney Int 2002;62:1724-1731.
    • (2002) Kidney Int , vol.62 , pp. 1724-1731
    • Chen, N.X.1    O'Neill, K.D.2    Duan, D.3
  • 54
    • 33750602868 scopus 로고    scopus 로고
    • Tissue calcification and serum phosphate levels - Is there a simple chemical explanation?
    • Hegbrant J, Karin, S, Lars-Fride O: Tissue calcification and serum phosphate levels - is there a simple chemical explanation? J Am Soc Neph 2003;14:694A.
    • (2003) J Am Soc Neph , vol.14
    • Hegbrant, J.1    Karin, S.2    Lars-Fride, O.3
  • 55
    • 14544283020 scopus 로고    scopus 로고
    • Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: A potential mechanism for accelerated vascular calcification in ESRD
    • Reynolds JL, Joannides AJ, Skepper JN, et al: Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: A potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 2004;15:2857-2867.
    • (2004) J Am Soc Nephrol , vol.15 , pp. 2857-2867
    • Reynolds, J.L.1    Joannides, A.J.2    Skepper, J.N.3
  • 56
    • 33750586535 scopus 로고    scopus 로고
    • Regulation of human smooth muscle cell calcification by type III sodium-dependent phosphate cotransporter
    • Li X, Giachelli CM: Regulation of human smooth muscle cell calcification by type III sodium-dependent phosphate cotransporter. J Am Soc Neph 2003;14:547A.
    • (2003) J Am Soc Neph , vol.14
    • Li, X.1    Giachelli, C.M.2
  • 57
    • 33750580824 scopus 로고    scopus 로고
    • The effect of calcium, phosphate, and calcitropic hormones on calcification of intact vessels in vitro
    • Lomashvili K, Cobbs SL, ONeill WC: The effect of calcium, phosphate, and calcitropic hormones on calcification of intact vessels in vitro. J Am Soc Neph 2003;14:691A.
    • (2003) J Am Soc Neph , vol.14
    • Lomashvili, K.1    Cobbs, S.L.2    Oneill, W.C.3
  • 59
    • 0036041981 scopus 로고    scopus 로고
    • Novel insights into uremic vascular calcification: Role of matrix Gla protein and alpha-2-Heremans Schmid glycoprotein/fetuin
    • Ketteler M, Vermeer C, Wanner C, et al: Novel insights into uremic vascular calcification: Role of matrix Gla protein and alpha-2-Heremans Schmid glycoprotein/fetuin. Blood Purif 2002;20:473-476.
    • (2002) Blood Purif , vol.20 , pp. 473-476
    • Ketteler, M.1    Vermeer, C.2    Wanner, C.3
  • 60
    • 1842513889 scopus 로고    scopus 로고
    • Deficiencies of calcium-regulatory proteins in dialysis patients: A novel concept of cardiovascular calcification in uremia
    • Ketteler M, Wanner C, Metzger T, et al: Deficiencies of calcium-regulatory proteins in dialysis patients: A novel concept of cardiovascular calcification in uremia. Kidney Int Suppl 2003:S84-S87.
    • (2003) Kidney Int Suppl
    • Ketteler, M.1    Wanner, C.2    Metzger, T.3
  • 61
    • 0036560596 scopus 로고    scopus 로고
    • Calciphylaxis: Emerging concepts in prevention, diagnosis, and treatment
    • Wilmer WA, Magro CM: Calciphylaxis: Emerging concepts in prevention, diagnosis, and treatment. Semin Dial 2002;15:172-186.
    • (2002) Semin Dial , vol.15 , pp. 172-186
    • Wilmer, W.A.1    Magro, C.M.2
  • 62
    • 14544268251 scopus 로고    scopus 로고
    • Serum levels of the fetuin-mineral complex correlate with artery calcification in the rat
    • Price PA, Williamson MK, Minh Thi Nguyen T, et al: Serum levels of the fetuin-mineral complex correlate with artery calcification in the rat. J Biol Chem 2003.
    • (2003) J Biol Chem
    • Price, P.A.1    Williamson, M.K.2    Minh Thi Nguyen, T.3
  • 63
    • 85047694301 scopus 로고    scopus 로고
    • The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification
    • Schafer C, Heiss A, Schwarz A, et al: The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003;112:357-366.
    • (2003) J Clin Invest , vol.112 , pp. 357-366
    • Schafer, C.1    Heiss, A.2    Schwarz, A.3
  • 64
    • 0037426081 scopus 로고    scopus 로고
    • Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: A cross-sectional study
    • Ketteler M, Bongartz P, Westenfeld R, et al: Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: A cross-sectional study. Lancet 2003;361:827-833.
    • (2003) Lancet , vol.361 , pp. 827-833
    • Ketteler, M.1    Bongartz, P.2    Westenfeld, R.3
  • 65
    • 0021316404 scopus 로고
    • The Framingham Heart Study: Review of epidemiological design and data, limitations and prospects
    • Higgins MW: The Framingham Heart Study: Review of epidemiological design and data, limitations and prospects. Prog Clin Biol Res 1984;147:51-64.
    • (1984) Prog Clin Biol Res , vol.147 , pp. 51-64
    • Higgins, M.W.1
  • 66
    • 0036259622 scopus 로고    scopus 로고
    • Cardiovascular calcification and disease in adult hemodialysis patients
    • Raggi P: Cardiovascular calcification and disease in adult hemodialysis patients. Dial Transplant 2002;31:393-400.
    • (2002) Dial Transplant , vol.31 , pp. 393-400
    • Raggi, P.1
  • 67
    • 0032759970 scopus 로고    scopus 로고
    • Long-term effects of sevelamer hydrochloride on the calcium X phosphate product and lipid profile of haemodialysis patients
    • Chertow GM, Burke SK, Dillon MA, et al: Long-term effects of sevelamer hydrochloride on the calcium X phosphate product and lipid profile of haemodialysis patients. Nephrol Dial Transplant 1999;14:2907-2914.
    • (1999) Nephrol Dial Transplant , vol.14 , pp. 2907-2914
    • Chertow, G.M.1    Burke, S.K.2    Dillon, M.A.3
  • 68
    • 0346270563 scopus 로고    scopus 로고
    • Calcimimetic agents and secondary hyperparathyroidism: Rationale for use and results from clinical trials
    • Goodman WG: Calcimimetic agents and secondary hyperparathyroidism: Rationale for use and results from clinical trials. Pediatr Nephrol 2003;18:1206-1210.
    • (2003) Pediatr Nephrol , vol.18 , pp. 1206-1210
    • Goodman, W.G.1
  • 69
    • 11144353767 scopus 로고    scopus 로고
    • Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis
    • Block GA, Martin KJ, de Francisco AL, et al: Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 2004;350:1516-1525.
    • (2004) N Engl J Med , vol.350 , pp. 1516-1525
    • Block, G.A.1    Martin, K.J.2    De Francisco, A.L.3
  • 70
    • 2442566636 scopus 로고    scopus 로고
    • Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels
    • Pennisi P, Signorelli SS, Riccobene S, et al: Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. Osteoporos Int 2004;15:389-395.
    • (2004) Osteoporos Int , vol.15 , pp. 389-395
    • Pennisi, P.1    Signorelli, S.S.2    Riccobene, S.3
  • 71
    • 0032079445 scopus 로고    scopus 로고
    • Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
    • Bucay N, Sarosi I, Dunstan CR, et al: Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998;12:1260-1268.
    • (1998) Genes Dev , vol.12 , pp. 1260-1268
    • Bucay, N.1    Sarosi, I.2    Dunstan, C.R.3
  • 72
    • 0029861325 scopus 로고    scopus 로고
    • Vitamin K status and bone mass in women with and without aortic atherosclerosis: A population-based study
    • Jie KG, Bots ML, Vermeer C, et al: Vitamin K status and bone mass in women with and without aortic atherosclerosis: A population-based study. Calcif Tissue Int 1996;59:352-356.
    • (1996) Calcif Tissue Int , vol.59 , pp. 352-356
    • Jie, K.G.1    Bots, M.L.2    Vermeer, C.3
  • 73
    • 0030724491 scopus 로고    scopus 로고
    • Mutation of the mouse klotho gene leads to a syndrome resembling ageing
    • Kuro-o M, Matsumura Y, Aizawa H, et al: Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997;390:45-51.
    • (1997) Nature , vol.390 , pp. 45-51
    • Kuro-o, M.1    Matsumura, Y.2    Aizawa, H.3
  • 74
    • 4544278392 scopus 로고    scopus 로고
    • Aortic calcification and the risk of osteoporosis and fractures
    • Schulz E, Arfai K, Liu X, et al: Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab 2004;89:4246-4253.
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 4246-4253
    • Schulz, E.1    Arfai, K.2    Liu, X.3
  • 75
    • 18144450809 scopus 로고    scopus 로고
    • Molecular targets of hyperphosphataemia in chronic renal failure
    • Miyamoto K, Ito M, Segawa H, et al: Molecular targets of hyperphosphataemia in chronic renal failure. Nephrol Dial Transplant 2003;18(suppl 3):iii79-iii80.
    • (2003) Nephrol Dial Transplant , vol.18 , Issue.SUPPL. 3
    • Miyamoto, K.1    Ito, M.2    Segawa, H.3
  • 76
    • 0038003153 scopus 로고    scopus 로고
    • Calcium and phosphate balance with quotidian hemodialysis
    • Lindsay RM, Alhejaili F, Nesrallah G, et al: Calcium and phosphate balance with quotidian hemodialysis. Am J Kidney Dis 2003;42:24-29.
    • (2003) Am J Kidney Dis , vol.42 , pp. 24-29
    • Lindsay, R.M.1    Alhejaili, F.2    Nesrallah, G.3
  • 78
    • 0033774502 scopus 로고    scopus 로고
    • Detection and quantification of cardiovascular calcifications with electron beam tomography to estimate risk in hemodialysis patients
    • Raggi P: Detection and quantification of cardiovascular calcifications with electron beam tomography to estimate risk in hemodialysis patients. Clin Nephrol 2000;54:325-333.
    • (2000) Clin Nephrol , vol.54 , pp. 325-333
    • Raggi, P.1
  • 79
    • 0036175283 scopus 로고    scopus 로고
    • Effects of excess calcium load on the cardiovascular system measured with electron beam tomography in end-stage renal disease
    • Raggi P: Effects of excess calcium load on the cardiovascular system measured with electron beam tomography in end-stage renal disease. Nephrol Dial Transplant 2002;17:332-335.
    • (2002) Nephrol Dial Transplant , vol.17 , pp. 332-335
    • Raggi, P.1
  • 80
    • 0036176161 scopus 로고    scopus 로고
    • National Kidney Foundation (NKF) K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
    • National Kidney Foundation (NKF) K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification: Am J Kidney Dis 2002;39:S1-S266.
    • (2002) Am J Kidney Dis , vol.39
  • 81
    • 0036071145 scopus 로고    scopus 로고
    • Sevelamer, a phosphate-binding polymer, is a non-absorbed compound
    • Plone MA, Petersen JS, Rosenbaum DP, et al: Sevelamer, a phosphate-binding polymer, is a non-absorbed compound. Clin Pharmacokinet 2002;41:517-523.
    • (2002) Clin Pharmacokinet , vol.41 , pp. 517-523
    • Plone, M.A.1    Petersen, J.S.2    Rosenbaum, D.P.3
  • 82
    • 0142187235 scopus 로고    scopus 로고
    • Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia
    • Cozzolino M, Staniforth ME, Liapis H, et al: Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia. Kidney Int 2003;64:1653-1661.
    • (2003) Kidney Int , vol.64 , pp. 1653-1661
    • Cozzolino, M.1    Staniforth, M.E.2    Liapis, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.